Skip to content
Review Open access

Red and near-infrared photobiomodulation in precision medicine: mechanisms, dosimetry, and clinical translation

Oct 2026 · Lasers in Medical Science · Vol 41 · 0 citations · 86 references
Medicine

TL;DR

This review places the biological effects, therapeutic indications, and safety profiles of ultraviolet, blue, and green light in comparative context, while focusing primarily on the mechanisms, dosimetry, and clinical translation of red and near-infrared photobiomodulation (PBM).

Abstract

Phototherapy is a non-invasive therapeutic modality that uses specific wavelengths of light to modulate biological processes and treat disease. Driven by advances in photobiology, regenerative medicine, and clinical technology, phototherapy has evolved from empirical heliotherapy into a mechanism-based intervention with expanding medical applications. This review places the biological effects, therapeutic indications, and safety profiles of ultraviolet, blue, and green light in comparative context, while focusing primarily on the mechanisms, dosimetry, and clinical translation of red and near-infrared photobiomodulation (PBM). Although ultraviolet and blue light therapies have established roles in dermatology and neonatal jaundice, their clinical use is limited by concerns such as photocarcinogenesis, retinal phototoxicity, and circadian disruption. In contrast, red and near-infrared light offer deeper tissue penetration and, when appropriately dosed, a comparatively low risk of direct photochemical injury. Through mitochondrial, redox, inflammatory, and other context-dependent signaling pathways, red/NIR PBM has been investigated in wound repair, chronic pain, osteoarthritis, musculoskeletal disorders, neurological conditions, and dermatological applications. As a representative quantitative example, a 2024 meta-analysis of 10 placebo-controlled randomized trials involving 542 participants with knee osteoarthritis found a moderate reduction in pain at rest with PBM compared with placebo (standardized mean difference, − 0.70; 95% confidence interval, − 1.10 to − 0.20), although the certainty of evidence was very low. However, broader clinical translation remains constrained by heterogeneous dosimetry, insufficiently standardized treatment protocols, and uneven evidence maturity across indications. To address these limitations, we propose a precision-oriented framework that links clinical target, tissue-optical context, wavelength selection, patient- and site-specific modifiers, dosimetric implications, measurable endpoints, and evidence maturity. This framework is intended to support treatment planning, parameter reporting, and prospective validation rather than to prescribe currently validated individualized dosing algorithms.

Read PDF

Similar papers

Review Open access Oct 2026

Applications of Oral Photomedicine in Dentistry: A Comprehensive Review of Visible Light Lasers, Photobiomodulation, and Photodynamic Therapy

Visible light lasers in the 400–700 nm range are used in dentistry for two main types of treatment, photobiomodulation (PBM) and photodynamic therapy (PDT). In PBM, low levels of light energy stimulate mitochondrial cytochrome c oxidase (CcOx); this increases adenosine triphosphate (ATP) production, changes reactive ox...

Zi-Qing Ye · 0 citations
Review Open access Oct 2026

The biological gray zone in dermatologic laser and energy-based procedures: From intended photobiomodulation to paradoxical effects

Dermatologic lasers and energy-based devices can produce biological responses ranging from intentional non- destructive modulation to target destruction. This narrative review distinguishes intentional photobiomodulation and low-fluence pigment modulation from an author-defined concept termed target-relative sub-therap...

Stefan Bigge · 0 citations
Review Open access Sep 2026

Phototherapy Strategies for Cancer Treatment: Mechanisms and Emerging Nanomaterials

This review systematically summarizes the latest research progress and material evolution trends in phototherapy and aims to provide design guidance for developing efficient, controllable, and clinically translatable photoresponsive materials for cancer phototherapy.

Fan Liu, Jun Huang · 0 citations
Review Open access Sep 2026

Photobiomodulation for skeletal muscle regeneration: mechanisms, dosimetry, and translational challenges

Photobiomodulation (PBM) has gained increasing attention as a non-invasive modality for enhancing skeletal muscle recovery; however, its clinical translation remains limited by inconsistencies in dosimetry, methodology, and reporting across studies. This review synthesizes over two decades of preclinical and clinical r...

Ryan Ahmed, Kevin L. Zhang, Rabab Hamzah et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.